YORVIPATH is a first-in-class PTH replacement therapy. A prodrug of parathyroid hormone (PTH [1-34]), YORVIPATH is administered subcutaneously once daily, with sustained release of active PTH designed ...

Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic manufacturing, today announced that it has ...

MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

Crestone's Best Sector Ideas are an attempt to identify the best in breed business models for major industry group sectors for long-term oriented investors. Anticipated performance over the next three ...

An exceptional earnings beat from Temple & Webster was driven by a simultaneous increase in both revenue and margins, with a ...

2. Clarity Pharmaceuticals. Clarity receives U.S. FDA Fast Track Designation for 64Cu-SAR-bisPSMA in biochemical recurrence of prostate cancer. https://www.claritypharmaceuticals.com/news/ftd-2/ ...

Company retains the prestigious blue seal for the North America and Asia-Pacific regions, in addition to red seal recognition in 10 countries ...

10-year contract extension expands coverage and capabilities to support first responders and community safety across the state ...

Pro Medicus continues to win contacts at an accelerating pace, leaving brokers to raise targets on a promising outlook and ...

SYDNEY, Feb. 19, 2025 /PRNewswire/ — Rising rents, fluctuating house prices, and property issues are making it harder for Australians to secure housing. According to the Real Property Report 2025, ...

Co-responsible for the local share market's positive performance thus far in February, following on from an already positive ...

Gold has seen an out-and-out trend day, with volumes in the futures building on the rally through US trade, despite the ...